| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,230 |
23,466 |
$2.86M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,594 |
17,742 |
$2.27M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,805 |
4,083 |
$1.73M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,528 |
11,935 |
$1.72M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,124 |
1,696 |
$549K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,897 |
3,524 |
$531K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,836 |
3,088 |
$528K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,921 |
3,380 |
$440K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,623 |
1,323 |
$408K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,548 |
3,187 |
$345K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,321 |
1,323 |
$320K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,732 |
789 |
$296K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,195 |
1,521 |
$285K |
| 59025 |
Fetal non-stress test |
1,841 |
874 |
$243K |
| G0378 |
Hospital observation service, per hour |
3,136 |
1,234 |
$229K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
761 |
652 |
$214K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,970 |
1,144 |
$163K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
697 |
584 |
$159K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
724 |
614 |
$158K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,453 |
1,084 |
$145K |
| 80053 |
Comprehensive metabolic panel |
14,584 |
10,989 |
$137K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,313 |
975 |
$130K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
685 |
603 |
$124K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,536 |
572 |
$110K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
458 |
364 |
$103K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
378 |
332 |
$99K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
137 |
119 |
$92K |
| 99215 |
Prolong outpt/office vis |
736 |
551 |
$79K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
859 |
758 |
$78K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
849 |
600 |
$76K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,642 |
5,763 |
$68K |
| 76801 |
|
656 |
551 |
$65K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
149 |
94 |
$54K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,485 |
19,008 |
$52K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,039 |
420 |
$52K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
523 |
460 |
$52K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
609 |
471 |
$49K |
| 81514 |
|
310 |
258 |
$49K |
| 84439 |
|
2,877 |
2,469 |
$48K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,640 |
3,131 |
$41K |
| 36415 |
Collection of venous blood by venipuncture |
15,480 |
12,999 |
$41K |
| 97162 |
|
834 |
724 |
$40K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
190 |
166 |
$40K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,523 |
1,375 |
$38K |
| 71046 |
Radiologic examination, chest; 2 views |
2,379 |
2,117 |
$36K |
| 95811 |
|
52 |
40 |
$33K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
214 |
196 |
$33K |
| 80061 |
Lipid panel |
2,327 |
2,111 |
$30K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,500 |
6,291 |
$28K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
658 |
597 |
$28K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
262 |
146 |
$27K |
| 96367 |
|
706 |
426 |
$26K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
493 |
378 |
$26K |
| 86780 |
|
1,433 |
1,280 |
$26K |
| 76830 |
Ultrasound, transvaginal |
647 |
570 |
$24K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
202 |
186 |
$23K |
| 82607 |
|
978 |
865 |
$21K |
| 74018 |
|
564 |
490 |
$20K |
| 86850 |
|
812 |
686 |
$20K |
| H1000 |
Prenatal care, at-risk assessment |
722 |
535 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,403 |
1,261 |
$17K |
| 72100 |
|
486 |
435 |
$16K |
| 71250 |
|
184 |
168 |
$16K |
| 73562 |
|
820 |
665 |
$16K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
82 |
80 |
$15K |
| 84702 |
|
1,007 |
694 |
$15K |
| 82728 |
|
876 |
791 |
$14K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
308 |
102 |
$14K |
| 86787 |
|
546 |
480 |
$14K |
| 83735 |
|
6,142 |
3,792 |
$13K |
| 93017 |
|
178 |
120 |
$13K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
579 |
224 |
$13K |
| 76536 |
|
116 |
100 |
$13K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
98 |
89 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,609 |
4,231 |
$12K |
| 85027 |
|
1,680 |
1,416 |
$12K |
| 87340 |
|
747 |
660 |
$12K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,295 |
5,859 |
$12K |
| 97535 |
Self-care/home management training, each 15 minutes |
379 |
273 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
564 |
471 |
$11K |
| 86900 |
|
841 |
704 |
$11K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
81 |
39 |
$11K |
| 80076 |
|
969 |
797 |
$11K |
| 70496 |
|
29 |
25 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,378 |
2,015 |
$10K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,017 |
900 |
$10K |
| 86803 |
|
776 |
681 |
$10K |
| 93975 |
|
81 |
70 |
$9K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
39 |
37 |
$9K |
| 86140 |
|
920 |
739 |
$9K |
| 83540 |
|
963 |
859 |
$9K |
| 73630 |
|
728 |
621 |
$9K |
| 73030 |
|
535 |
450 |
$9K |
| 70491 |
|
29 |
28 |
$8K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
659 |
598 |
$8K |
| 90715 |
|
507 |
456 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
618 |
498 |
$8K |
| 86762 |
|
542 |
477 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
563 |
350 |
$7K |
| 97010 |
|
197 |
77 |
$7K |
| 84484 |
|
4,219 |
3,203 |
$7K |
| 59430 |
|
61 |
55 |
$7K |
| 82570 |
|
831 |
715 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
3,812 |
3,189 |
$6K |
| 82950 |
|
555 |
510 |
$6K |
| 83550 |
|
798 |
713 |
$6K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
46 |
45 |
$6K |
| 97166 |
|
155 |
130 |
$6K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
912 |
838 |
$5K |
| 82746 |
|
536 |
480 |
$5K |
| 97116 |
|
348 |
154 |
$5K |
| 70486 |
|
82 |
67 |
$5K |
| 86901 |
|
841 |
704 |
$5K |
| 76770 |
|
37 |
24 |
$5K |
| 73610 |
|
526 |
464 |
$5K |
| 83970 |
|
172 |
148 |
$5K |
| 85014 |
|
563 |
503 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
129 |
127 |
$5K |
| 84481 |
|
334 |
302 |
$5K |
| 73130 |
|
402 |
348 |
$5K |
| 81025 |
|
7,553 |
6,507 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
713 |
606 |
$4K |
| 83525 |
|
175 |
156 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
122 |
65 |
$4K |
| 71271 |
|
25 |
25 |
$4K |
| 0012A |
|
93 |
88 |
$3K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
27 |
27 |
$3K |
| 73502 |
|
199 |
168 |
$3K |
| 81003 |
|
11,543 |
10,205 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,531 |
3,864 |
$3K |
| 82043 |
|
498 |
450 |
$3K |
| 93225 |
|
27 |
24 |
$3K |
| 81001 |
|
947 |
802 |
$3K |
| 85610 |
|
4,788 |
3,025 |
$3K |
| 0011A |
|
98 |
96 |
$3K |
| 85018 |
|
651 |
556 |
$3K |
| 85652 |
|
556 |
470 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
96 |
84 |
$2K |
| 96376 |
|
2,019 |
909 |
$2K |
| 83880 |
|
1,173 |
919 |
$2K |
| 12011 |
|
14 |
13 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
713 |
606 |
$2K |
| 84100 |
|
562 |
375 |
$2K |
| 73110 |
|
184 |
159 |
$2K |
| 97161 |
|
32 |
28 |
$2K |
| 83615 |
|
407 |
313 |
$2K |
| 99443 |
|
57 |
48 |
$1K |
| 84550 |
|
411 |
324 |
$1K |
| 92523 |
|
17 |
13 |
$1K |
| 83690 |
|
3,568 |
2,803 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
84 |
84 |
$1K |
| 84146 |
|
80 |
69 |
$1K |
| 82565 |
|
146 |
119 |
$1K |
| 72072 |
|
30 |
27 |
$1K |
| 87507 |
|
15 |
14 |
$1K |
| 87077 |
|
669 |
553 |
$1K |
| 85379 |
|
1,410 |
1,192 |
$894.52 |
| 84132 |
|
684 |
402 |
$886.79 |
| 83655 |
|
57 |
55 |
$854.34 |
| 94664 |
|
1,049 |
750 |
$848.80 |
| 87186 |
|
434 |
364 |
$804.81 |
| 84153 |
|
69 |
61 |
$773.11 |
| 83605 |
|
1,692 |
1,264 |
$765.24 |
| 82550 |
|
241 |
180 |
$743.53 |
| 95806 |
|
12 |
12 |
$709.91 |
| 90686 |
|
29 |
29 |
$693.03 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$683.51 |
| 77080 |
|
12 |
12 |
$681.28 |
| 84156 |
|
209 |
175 |
$665.04 |
| 85730 |
|
1,106 |
895 |
$637.61 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,584 |
1,434 |
$637.36 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
28 |
28 |
$633.39 |
| 82105 |
|
41 |
38 |
$583.80 |
| 80074 |
|
55 |
52 |
$531.14 |
| J3490 |
Unclassified drugs |
87 |
77 |
$528.17 |
| 87040 |
|
668 |
500 |
$514.62 |
| 73080 |
|
20 |
16 |
$504.35 |
| 86038 |
|
27 |
26 |
$494.34 |
| 84403 |
|
38 |
37 |
$450.00 |
| 82784 |
|
41 |
40 |
$406.94 |
| 84145 |
|
469 |
334 |
$389.10 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
193 |
174 |
$370.15 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
433 |
321 |
$367.80 |
| 71101 |
|
32 |
24 |
$350.63 |
| 82951 |
|
13 |
12 |
$243.58 |
| 82248 |
|
27 |
24 |
$237.06 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
97 |
78 |
$214.71 |
| 99442 |
|
21 |
12 |
$189.77 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
100 |
85 |
$160.96 |
| 90656 |
|
14 |
14 |
$160.73 |
| 82952 |
|
13 |
12 |
$153.01 |
| 84460 |
|
17 |
15 |
$134.27 |
| 73590 |
|
16 |
12 |
$125.46 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
729 |
447 |
$117.83 |
| 82077 |
|
145 |
115 |
$115.69 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
379 |
263 |
$54.54 |
| J1644 |
Injection, heparin sodium, per 1000 units |
89 |
42 |
$48.93 |
| J7050 |
Infusion, normal saline solution, 250 cc |
679 |
358 |
$47.47 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,871 |
1,418 |
$43.12 |
| 82310 |
|
13 |
13 |
$38.47 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
359 |
345 |
$35.56 |
| J2704 |
Injection, propofol, 10 mg |
691 |
541 |
$35.13 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
126 |
80 |
$32.63 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
172 |
122 |
$31.95 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
213 |
174 |
$29.28 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
289 |
238 |
$24.13 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,166 |
966 |
$19.27 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
926 |
628 |
$13.88 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
762 |
490 |
$13.66 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,467 |
1,159 |
$12.72 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
802 |
417 |
$10.23 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
98 |
51 |
$10.01 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
92 |
28 |
$8.39 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
217 |
180 |
$5.49 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
231 |
145 |
$5.24 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
36 |
25 |
$5.15 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,474 |
2,784 |
$4.59 |
| 81002 |
|
24 |
15 |
$3.48 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
344 |
244 |
$3.13 |
| 82803 |
|
95 |
69 |
$3.10 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
391 |
335 |
$2.05 |
| 91301 |
|
197 |
190 |
$1.86 |
| J2060 |
Injection, lorazepam, 2 mg |
46 |
40 |
$1.06 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
84 |
75 |
$0.99 |
| J3480 |
Injection, potassium chloride, per 2 meq |
68 |
37 |
$0.62 |
| 82150 |
|
56 |
52 |
$0.28 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
30 |
26 |
$0.24 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
831 |
724 |
$0.00 |
| 94760 |
|
633 |
399 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
131 |
80 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
65 |
39 |
$0.00 |
| 80047 |
|
13 |
13 |
$0.00 |
| 87205 |
|
16 |
12 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
27 |
27 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
20 |
13 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
70 |
39 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
100 |
95 |
$0.00 |
| 73140 |
|
12 |
12 |
$0.00 |
| 29125 |
|
13 |
12 |
$0.00 |
| 82010 |
|
18 |
14 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
15 |
13 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
12 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
20 |
13 |
$0.00 |